Brean, Murray & Carret Downgrades American Oriental Bioengineering To Hold, Removes PT

Symbols: AOB
Share

Brean, Murray Carret & Co. has downgraded American Oriental Bioengineering (NYSE: AOB) from Buy to Hold and has removed its $3.70 price target.


 
 
< Previous
UPDATE: Dahlman Rose Downgrades EXCO Resources to Hold (XCO)
Next >
Benzinga's Top Downgrades (STO, FSIN, CW, AJG)
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust